Endo International | ENDP - Créances Commerciales



Créances Commerciales Changement Date
AbbVie USD 12.77B 132M 2025-09
Amarin USD 127.31M 8.18M 2025-09
ANI Pharmaceuticals USD 281.08M 28.46M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Coherus Biosciences USD 62.44M 59.9M 2025-03
Eli Lilly USD 19.46B 2.25B 2025-09
Heron Therapeutics USD 67.04M 6.9M 2024-09
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
Merck USD 12.12B 596M 2025-09
Novartis USD 8.98B 192M 2025-09
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Phibro Animal Health USD 160.78M 8.67M 2024-09
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Takeda JPY 757.92B 55.68B 2025-12
Teva Pharmaceutical Industries USD 3.71B 101M 2025-12
Xeris Pharmaceuticals USD 53.75M 700K 2025-09
Zoetis USD 1.59B 49M 2025-12